In addition to HDAC inhibitors, several experimental miRNA-based therapies for psychiatric disorders like schizophrenia, MDD, anxiety, and neurodevelopmental disorders are currently under investigation (122). The gene discussed is HDAC9; the disease is schizophrenia.